Sildenafil inhibits chronically hypoxic upregulation of canonical transient receptor potential expression in rat pulmonary arterial smooth muscle sively leading to heart failure and increased mortality. PH is featured by increased pulmonary artery pressure (PAP) and structural alterations in the walls of the distal pulmonary arteries (PA), known as pulmonary vascular remodeling. Diffusive alveoli hypoxia is thought to be an important trigger that causes these changes. Exposure to chronic hypoxia (CH) leads to chronically hypoxic pulmonary hypertension (CHPH) in animal models, i.e., rat and mouse. Despite the numerous progresses in elucidating the pathophysiological and functional changes of CHPH, the underlying cellular and molecular mechanisms remain unclear.
In pulmonary arterial smooth muscle cells (PASMCs), global increases in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) are associated with increased tone and proliferation (28) . We and others have previously found that CH elevated basal [Ca 2ϩ ] i in PASMCs due in large part to enhanced storeoperated Ca 2ϩ entry (SOCE) through store-operated Ca 2ϩ channels (SOCC) (15, 33) . SOCC are thought to be composed of canonical transient receptor potential (TRPC) proteins (19, 20) . Of the three most abundantly expressed TRPC isoforms (TRPC1, TRPC4, and TRPC6) in pulmonary arterial smooth muscle (16) , mRNA and protein expression of TRPC1 and TRPC6 is selectively upregulated by CH (33) . Sildenafil citrate, a potent and selective type V phosphodiesterase (PDE5) inhibitor, has recently been approved by the Food and Drug Administration as an orally administered drug for treatment of PH. Studies in animal models indicate that sildenafil significantly attenuated the characteristics of CHPH, including PAP, pulmonary vascular muscularization, and right ventricular hypertrophy (2, 10, 25, 41) . Expanding clinical studies have demonstrated the efficacy of sildenafil in decreasing mean PAP and pulmonary vascular resistance and in improving cardiac index and exercise tolerance in PH patients (3) . Sildenafil has been shown to be able to reduce basal [Ca 2ϩ ] i acutely in PASMCs and vascular tone in PA smooth muscle from chronically hypoxic rats (21) . The molecular mechanisms of those beneficial effects of sildenafil have largely been attributed to its ability to increase the intracellular concentration of cGMP, which exerts relaxation and growth inhibition on vascular smooth muscle cells (18, 31) , or to its ability to affect calcium sensitization through inhibition of the RhoA/Rho kinase pathway (10) . However, little has been studied about its chronic effect on basal [Ca 2ϩ ] i in PASMCs when long-term administration occurs.
This study was designed and performed to test the hypothesis that sildenafil decreases CH-induced changes of PAP through downregulation of TRPC expression, which in turn reduces SOCE and basal [Ca 2ϩ ] i in PASMCs.
METHODS
Exposure of animals to chronic hypoxia and treatment with sildenafil. All procedures were approved by the Animal Care and Use Committee of The Johns Hopkins University School of Medicine. Adult male Wistar rats (175-300 g) were placed in a hypoxic chamber for 21 days as previously described (27, 33) . The chamber was continuously flushed with a mixture of room air and N 2 to maintain 10 Ϯ 0.5% O2 and CO2 Ͻ 0.5%. Chamber O2 concentration was continuously monitored using a PRO-OX unit (RCI Hudson, Anaheim, CA). Animals were exposed to room air for 10 min every 2 days for replenishing drug, food and water or for change of cage. Normoxic control animals were kept in room air next to the hypoxic chamber. Four groups were examined: 1) a normoxic control group, 2) a hypoxic control group, 3) a normoxic group treated with sildenafil (50 mg · kg Ϫ1 · day Ϫ1 ), and 4) a hypoxic group treated with sildenafil (50 mg · kg Ϫ1 · day Ϫ1 ). Sildenafil (sildenafil citrate tablets, Pfizer, Sandwich, England) was administered in the drinking water and initiated from the day the animals were placed in the chamber. Drinking volume was measured daily over a period of 1 wk before the onset of treatment to calculate the uptake of water per day. The concentration of sildenafil in the drinking water was then adjusted accordingly.
Hemodynamic measurements. Measurements including right ventricular pressure and right ventricular hypertrophy were done as previously described (26) . Briefly, at the end of chronic hypoxic exposure (10% O 2 for 21 days), rats were anesthetized with pentobarbital sodium (65 mg/kg ip). An incision was made in the abdomen, resulting in the visualization of the diaphragm. A heparinized salinefilled 23-gauge needle connected to a pressure transducer was inserted through the diaphragm into the right ventricle (RV), the right ventricular systolic pressure (RVSP) was recorded and measured, and the mean right ventricular pressure (RVP) was analyzed by PowerLab systems (ML785 PowerLab/8SP, ADInstruments, Colorado Springs, CO) as described before (26) . The right ventricle was dissected from the left ventricle (LV) and septum (S) after removal of the atria. The ventricles were blotted dry and weighed. Total ventricular weight (g), left ventricular weight (g), and ratio of RV to LV plus S [RV/(LV ϩ S)] were assessed. After pressure recording, whole blood was collected via right ventricle puncture with K 2EDTA as an anticoagulant, filled in capillary tubes (0.5 mm outside diameter, VWR Scientific), centrifuged for 5 min at 7,000 rpm, and read on a hematocrit chart (VWR Scientific).
Preparation of pulmonary arteries and pulmonary arterial smooth muscle cells. As previously described (32) , distal (Ͼ4th generation) intrapulmonary arteries were dissected from lungs of male Wistar rats (300 -500 g body wt) anesthetized with pentobarbital sodium (65 mg/kg ip). Adventitia was removed from the isolated PA, and endothelium was denuded by opening the vessel longitudinally and rubbing the luminal surface with a cotton swab. PASMCs were harvested from these PA smooth muscle enzymatically, plated onto 25-mm coverslips in six-well culture dishes, and incubated for 3-4 days in smooth muscle growth media 2 (Clonetics, Walkersville, MD) containing 5% serum in a humidified atmosphere of 5% CO 2-95% air at 37°C. Cellular purity of the cultures was assessed by morphological appearance under phase-contrast microscopy and immunofluorescence staining for ␣-actin under fluorescence microscopy (32) . Cells were growth arrested in smooth muscle basic media (SMBM, Clonetics) containing 0.3% serum for 24 h, then exposed to hypoxia (4% O 2-5% CO2) or normoxia in the presence of 300 nM sildenafil (Pfizer) or vehicle dimethyl sulfoxide (DMSO) for 60 h.
Small interference RNA transfection. PASMCs at 50 -60% confluence were transfected with 25 nM siGENOME SMARTpool (Dharmacon, Lafayette, CO) of nontargeting control small interference (si)RNA (siNT) or siRNA targeted to TRPC1 (siT1, gene accession no. NM_053558), or TRPC6 (siT6, gene accession no. NM_053559) using GeneSilencer (Genlantis, San Diego, CA) as carrier for 6 h in serum-free SMBM. Serum was then added to the culture to a final concentration of 0.3%, and cells were subjected to hypoxia (4% O 2-5% CO2) or normoxia exposure for 60 h before mRNA, protein, or calcium assay.
Measurement of intracellular Ca 2ϩ . Coverslips with PASMCs loaded with 7.5 M Fura-2 (Molecular Probes, Eugene, OR) for 60 min at 37°C under an atmosphere of 5% CO2-95% air were mounted in a closed polycarbonate chamber clamped in a heated aluminum platform (PH-2, Warner Instrument, Hamden, CT) on the stage of a Nikon TSE 100 Ellipse inverted microscope (Melville, NY). The chamber was perfused at 0.5-1 ml/min with Krebs-Ringer bicarbonate solution (KRBS). The KRBS, which contained (in mM) 118 NaCl, 4.7 KCl, 2.5 CaCl2, 0.57 MgSO4, 1.18 KH2PO4, 25 NaHCO3, and 10 glucose, was equilibrated with 16% O 2-5% CO2 at 38°C in heated reservoirs and led via stainless steel tubing and a manifold to an in-line heat exchanger (SF-28, Warner Instrument) before it entered the cell chamber. A dual channel heater controller (TC-344B, Warner Instrument) was connected to the heat exchanger to control its temperature. This system maintained temperature at 37°C and oxygen tension at 112 Ϯ 2.0 mmHg at the coverslip. The cells were perfused for 10 min to remove extracellular dye, and ratiometric measurement of Fura-2 fluorescence was performed at 12-to 30-s intervals using a collimated light beam from a xenon arc lamp filtered by interference filters at 340 and 380 nm and focused onto PASMCs visualized with a ϫ20 fluorescence objective (Super Fluor 20, Nikon, Torrance, CA). Light emitted from the cells at 510 nm was returned through the objective and detected by a cooled charge-coupled device imaging camera. An electronic shutter (Vincent Associates, Rochester, NY) was used to minimize photobleaching. Protocols were executed and data collected on-line with InCyte software (Intracellular Imaging, Cincinnati, OH RNA isolation and measurement by real-time quantitative polymerase chain reaction. Total RNA was extracted using TRIzol method for deendothelialized distal PA, or using RNeasy kit (Qiagen, Valencia, CA) for PASMCs, as previously described (16, 32, 33) . DNA contamination in RNA preparations was removed by on-column DNase digestion using RNeasy column and RNase-free DNase (Qiagen).
Reverse transcription was performed using iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) with reaction mixture containing 1 g total RNA in a 20-l volume. cDNA of rat TRPC1, TRPC6, or 18s was amplified by real-time quantitative PCR (qPCR) using QuantiTect SYBR Green PCR Master Mix (Qiagen) in a iCyclerIQ real-time PCR detection system (Bio-Rad), as described previously (16) . Primer sequences in the measurements were 5=-AGCCTCTTGACAAAC-GAGGA-3= (sense) and 5=-ACCTGACATCTGTCCGAACC-3= (antisense) for TRPC1, and 5=-TACTGGTGTGCTCCTTGCAG-3= (sense) and 5=-GAGCTTGGTGCCTTCAAATC-3= (antisense) for TRPC6. Primers for 18s (Rn_Rnr1_1_SG QuantiTect Primer Assay) were from Qiagen. Relative concentration of each transcript was calculated using the Pfaffl method (23). Efficiency for each gene was determined from five-point serial dilutions of an unknown cDNA sample (PA or PASMCs). The expression of TRPC1 and TRPC6 was normalized to 18s in the same sample.
Protein isolation and measurement by Western blotting. Deendothelialized PA or PASMCs samples were homogenized by sonication in Laemmli sample buffer containing 62.5 mM Tris · HCl (pH 6.8), 2% sodium dodecyl sulfate (SDS), 10% glycerol, 5% protease inhibitor cocktail, 1 mM EDTA, and 200 M 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride. Total protein concentration in the homogenates was determined by the bicinchoninic acid protein assay (Pierce, Rockford, IL) using bovine serum albumin as a standard. Homogenates were denatured by adding dithiothreitol to 150 mM and heating at 95°C for 3 min. Homogenate proteins were resolved by 10% SDS-PAGE calibrated with prestained protein molecular weight markers (Precision Plus, Bio-Rad, Carlsbad, CA). Separated proteins were transferred to polyvinylidene difluoride membranes (pore size 0.45 M, Bio-Rad). Membranes were blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.2% Tween 20 and blotted with affinity-purified polyclonal antibodies specific for TRPC1 (Sigma, St. Louis, MO), TRPC6 (Alomone Laboratories, Jerusalem, Israel), or monoclonal antibody against ␣-actin (Sigma). The membranes were then washed for 15 min 3 times and incubated with horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse IgG for 1 h. Bound antibodies were detected using an enhanced chemiluminescence system (ECL, GE Healthcare, Piscataway, NJ).
Materials and drugs. Unless otherwise specified, all reagents were obtained from Sigma Chemical. Sildenafil was a gift from Pfizer. Fura-2 AM (Invitrogen, Carlsbad, CA) was prepared on the day of the experiment as a 2.5 mM stock solution in DMSO. Stock solutions of 30 mM CPA and 30 mM nifedipine were made in DMSO.
Statistical analysis. Data are expressed as means Ϯ SE, and n is the number of experiments, which equals the number of animals providing PA or cells. When Fura-2 fluorescence was measured, the number of cells in each experiment was 20 -30, as indicated in RESULTS and figure legends. Statistical analyses were performed using analysis of variance and Students t-test. If significant F-ratios were obtained with the former, pairwise comparison of means was conducted with t-tests. When necessary, a Bonferroni correction was used to adjust level of significance for multiple comparisons. Otherwise, differences were considered significant when P Ͻ 0.05. [Ca 2ϩ ] i in PASMCs exposed to prolonged hypoxia. As shown in Fig. 1 (Fig. 2, A and B) .
RESULTS

Sildenafil inhibited the increases of basal
Because the increase in [Ca 2ϩ ] i caused by restoration of extracellular Ca 2ϩ can be affected by factors other than SOCE, such as changes in membrane potential, we also measured the rate at which Mn 2ϩ quenched Fura-2 fluorescence, which is thought to reflect Ca 2ϩ influx more specifically. As seen in Fig.  2C , in the presence of CPA and nifedipine, Fura-2 fluorescence excited at 360 nm (F 360 Fig. 2, E and F) , suggesting that the effect of sildenafil on SOCE evaluated in our study is unlikely to be due to changes in membrane potential.
Sildenafil inhibited the increases of TRPC expression in PASMCs exposed to prolonged hypoxia. Compared with normoxic control cells, the mRNA (Fig. 3, A and B) and protein expression (Fig. 3, C and D) of TRPC1 and TRPC6 was increased in PASMCs exposed to prolonged hypoxia. Treatment with sildenafil attenuated these increases in hypoxic cells but did not alter their expression level in normoxic cells (Fig. 3) .
Knockdown of TRPC1 or TRPC6 expression reduced the increases of SOCE and basal [Ca 2ϩ ] i in PASMCs exposed to prolonged hypoxia. To determine the cause and effect relationship between increases of TRPC1 or TRPC6 expression and the hypoxic increases of SOCE and basal [Ca 2ϩ ] i in PASMCs, we applied loss of function approach by knocking down the endogenous gene expression of TRPC1 or TRPC6 using their specific siRNA, followed by measurement of SOCE and basal [Ca 2ϩ ] i . Similar to the above observation in nontransfected PASMCs, exposure to prolonged hypoxia increased mRNA and protein expression of TRPC1 and TRPC6 about 50% to 150% in cells treated with siNT (Fig. 4) . Compared with siNT-transfected hypoxic cells, treatment of TRPC1 by siT1 under hypoxic conditions reduced the expression of TRPC1 mRNA by 92.4 Ϯ 1.3% (P Ͻ 0.01; Fig. 4A ) and protein by 81.3 Ϯ 0.2% (P Ͻ 0.01; Fig. 4 , B and C) without causing significant change in TRPC6 expression; similarly, siT6 treatment reduced TRPC6 mRNA by 93.9 Ϯ 0.6% (P Ͻ 0.01; Fig.  4A ) and protein by 86.4% Ϯ 1.1% (P Ͻ 0.01; Fig. 4, B and C) without altering the level of TRPC1 expression. In PASMCs exposed to siNT, SOCE assessed by extracellular [Ca 2ϩ ] restoration was increased from 152 Ϯ 6.1% in normoxic cells to 391 Ϯ 22.5% in hypoxic cells (P Ͻ 0.001; Fig. 5, A and B) . Knockdown of TRPC1 by siT1 or of TRPC6 by siT6 under hypoxic conditions did not alter the initial transient increase in [Ca 2ϩ ] i during Ca 2ϩ -free perfusion; however, SOCE in cells treated with siT1 (211 Ϯ 3.5%), and treated with siT6 (277 Ϯ 13.7%) were both reduced as compared with siNT treated hypoxic cells, although still greater than that in normoxic siNT cells. The reduction by siT1 was greater than that by siT6 (P Ͻ 0.05; Fig. 5B ). Similarly, SOCE assessed by Mn 2ϩ quenching was increased from 33 Ϯ 1.6% in normoxic cells to 59 Ϯ 2.6% in hypoxic cells (P Ͻ 0.01; Fig.  5, C and D) . Knockdown of TRPC1 by siT1, or of TRPC6 by siT6, both caused slower rate of Mn 2ϩ quenching compared with siNT-treated hypoxic cells (Fig. 5, C and D) : SOCE with siT1 was reduced to 37 Ϯ 0.9% (P Ͻ 0.01), and to 43 Ϯ 1.2% with siT6 (P Ͻ 0.01). Again, the reductive effect of siT1 on SOCE was greater than siT6 (P Ͻ 0.05; Fig. 5D ). Somewhat different from SOCE assessed by extracellular [Ca 2ϩ ] restoration, Mn 2ϩ quenching in siT1-treated hypoxic cells was not different from that in normoxic siNT cells, whereas in siT6 cells, it was still higher than that in normoxic siNT cells.
Consequently, knockdown of TRPC1 by siT1 and of TRPC6 by siT6 under hypoxic conditions were both associated with reduced levels of basal [Ca 2ϩ ] i compared with siNT-treated hypoxic PASMCs (162 Ϯ 5.8% in siT1, 182 Ϯ 6.1% in siT6, and 219 Ϯ 9.0% in siNT cells); however, neither of these reductions was sufficient to normalize the basal [Ca 2ϩ ] i to the level (109 Ϯ 5.3%) in normoxic siNT cells (Fig. 6) . The reductive effect of siT1 on hypoxic increase of basal [Ca 2ϩ ] i was greater than that of siT6.
Sildenafil inhibited the hemodynamic parameters of CHPH in rats. Rats exposed to CH (10% O 2 for 21 days) developed CHPH. As shown in Fig. 4 , the mean RVP was increased from 10.0 Ϯ 0.45 mmHg (normoxic control) to 27.8 Ϯ 1.08 mmHg (hypoxic control), and RVSP increased from 26.7 Ϯ 1.08 mmHg (normoxic control) to 57.4 Ϯ 2.15 mmHg in hypoxic animals (Fig. 7B ). This effect of CH was accompanied by right (Fig. 7C) .
Weighing of the animals every 2 days revealed that, following an initial weight loss on initiation of sildenafil and hypoxia, all the animals maintained or increased body weight throughout the study (data not shown). In addition, weight ratios (ϫ10 Ϫ2 ) of liver to body (3.76 Ϯ 0.135, 3.79 Ϯ 0.146, 3.75 Ϯ 0.114, and 3.73 Ϯ 0.128, respectively, for normoxia control, ajpcell.physiology.org normoxia with sildenafil, hypoxia control, and hypoxia with sildenafil animals; n ϭ 6 in each group) and ratios (ϫ10
Ϫ3
) of kidney to body (6.41 Ϯ 0.144, 6.08 Ϯ 0.193, 6.36 Ϯ 0.232, and 6.27 Ϯ 0.288, respectively, for normoxia control, normoxia with sildenafil, hypoxia control, and hypoxia with sildenafil animals; n ϭ 6 in each group) were not changed by hypoxia exposure and/or sildenafil treatment, suggesting good tolerance to these treatments. In contrast, CH caused increases of hematocrit (%) in both control (70 Ϯ 1.18 for hypoxia vs. 43 Ϯ 0.48 for normoxia; n ϭ 6 each, P Ͻ 0.05) and sildenafil-treated animals (67 Ϯ 1.54 for hypoxia vs. 44 Ϯ 0.76 for normoxia; n ϭ 6 each, P Ͻ 0.05); these hypoxic changes were not different from each other.
Sildenafil inhibited TRPC1 and TRPC6 expression in distal pulmonary arteries from chronically hypoxic rats. Similar to our previous observations (33) and to the above results in PASMCs exposed to prolonged hypoxia, mRNA (Fig. 8, A and B) and protein (Fig. 8, C and D) expression levels of TRPC1 and TRPC6 were both increased in endothelium-denuded distal PA from rats exposed to CH (10% O 2 , 21 days). Treatment with sildenafil markedly suppressed these hypoxic increases in chronically hypoxic animals. The levels of TRPC1 and TRPC6 expression were not different from each other in distal PA from normoxic control animals with or without sildenafil treatment (Fig. 8) .
DISCUSSION
The present study demonstrated that sildenafil inhibited hypoxia-induced increases in basal [Ca 2ϩ ] i in PASMCs likely through its inhibitory action on the expression of TRPC proteins, contributing to its beneficial effects in the treatment of CHPH.
Exposure to prolonged hypoxia ex vivo (4% O 2 , 60 h) led to increase of basal [Ca 2ϩ ] i in PASMCs from normoxic rats (Fig.  1) , consistent with our previous observations (33 ] i in PASMCs obtained from hypoxic rats and suggested that the acute effect was due to a decrease in calcium release from internal store and activation of calcium reuptake mechanisms. Michelakis et al. (17) demonstrated that sildenafil could activate large-conductance calcium-sensitive potassium channels in PASMCs; thus it may exert restoration of membrane potential and decrease the hypoxic increase of [Ca 2ϩ ] i . In vascular smooth muscle, global increases in [Ca 2ϩ ] i can be caused by Ca 2ϩ release from internal storage sites, such as sarcoplasmic reticulum (SR), and/or Ca 2ϩ influx from extracellular fluid through VDCC, receptor-operated Ca 2ϩ channels (ROCC), or SOCC (11, 28, 33) . In cultured PASMCs exposed to prolonged hypoxia ex vivo, both SOCC and VDCC were found to contribute to the hypoxic increase in basal [Ca 2ϩ ] i (37); however, in PASMCs isolated from chronically hypoxic rats, previous studies suggest that the maintenance of elevated [Ca 2ϩ ] i requires Ca 2ϩ influx through pathways other than L-type VDCC (27) . Moreover, we demonstrated that the enhanced SOCE contributed to this elevation of [Ca 2ϩ ] i (33, 34) . We therefore focused on determination of the effect of sildenafil on SOCE in this study.
Consistently, we found that SOCE, assessed by measuring Ca 2ϩ bound Fura-2 fluorescence as direct indicator of [Ca 2ϩ ] i increase following store depletion and extracellular [Ca 2ϩ ] restoration, was greater in PASMCs exposed to prolonged hypoxia ex vivo compared with that measured in normoxic PASMCs (Fig. 2) . Because this approach for SOCE assessment could be affected by other factors, such as membrane potential, cytoplasmic calcium buffering, and Ca 2ϩ efflux through plasmalemmal Ca 2ϩ -ATPases and Na ϩ /Ca 2ϩ exchange, we also applied Mn 2ϩ quenching method, which was thought to be a more specific evaluation for Ca 2ϩ entry (20) . In the absence of Mn 2ϩ , no significant decrease in F 360 was observed in PASMCs cultured under either normoxic or hypoxic conditions. Following depletion of intracellular Ca 2ϩ stores with CPA, which maximally activates SOCC, addition of Mn 2ϩ caused significantly greater quenching of F 360 in PASMCs exposed to hypoxia (Fig. 2, C and D) According to previous reports, Ca 2ϩ entry could be altered by membrane potential independent of VDCC, or store depletion in skeletal muscle cells and endothelial cells (7, 8, 38) . In this case, the SOCE assessment via Mn 2ϩ quenching could also be influenced by changes of membrane potential. It is unclear whether this happens in PASMCs. We therefore tested it through substitution of Na ϩ with K ϩ in the perfusate, which provided a chemical clamp of membrane potential (E K ) at about Ϫ5 mV according to Nernst equation: (35) . The K ϩ substitution did not cause significant change in the rate of Mn 2ϩ quenching, suggesting that the inhibitory effect of sildenafil on hypoxic increases of SOCE is unlikely to be due to influences of membrane potential change.
The decrease in SOCE by sildenafil treatment could be through decreases in 1) Ca 2ϩ release from SR, 2) the activation ]i in PASMCs treated with siNT, siT1, or siT6 for 60 h under normoxic or hypoxic (4% O2) conditions. Bar values are means Ϯ SE; n ϭ 4 in each group. *P Ͻ 0.001 vs. normoxic siNT, **P Ͻ 0.05 vs. both normoxic and hypoxic siNT, and §P Ͻ 0.05 vs. hypoxic siT1. (12), and activation of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (7), suggest an inhibitory role of sildenafil in agonist (i.e., angiotensin II and phenylephrine)-stimulated calcium release from SR (21); however, in our data (Fig. 2) , the transient increase in [Ca 2ϩ ] i caused by CPA during perfusion with Ca 2ϩ -free KRBS was not different between sildenafil and vehicle treatment during either normoxia or hypoxia exposure, suggesting similar SR Ca 2ϩ release and therefore similar store depletion. One possible explanation for this discrepancy is that the effect of sildenafil on calcium release might be covered by CPA treatment, which caused complete depletion of SR Ca 2ϩ stores. On the other hand, it is also likely that the decrease in SOCE in cells treated with sildenafil resulted from reduced activation of SOCC through effects of sildenafil on the channels themselves or the transduction mechanisms linking store depletion to channel activation. Evidence in support of this assumption is that the nitric oxide/cGMP/PKG pathway was found to mediate inhibition of SOCE in human glomerular mesangial cells by phosphorylating vasodilator-stimulated phosphoprotein associated with TRPC4 (36) , and negatively regulate TRPC6 channel activity in a heterologous expression system in human embryonic kidney 293 cells and in rat embryonic aortic myocytes A7r5 (30) . In addition, PKG may inactivate human TRPC3/6/7 by phosphorylation at the sites of Thr11 and Ser263, which are conserved in members of the TRPC3/6/7 subfamily (14, 38) . Further investigation is needed to confirm the effects of sildenafil on the transduction mechanism linking store depletion to channel activation.
To evaluate the effect of sildenafil on the number of SOCC, we quantified the expression of TRPCs, which are believed to compose SOCC. Consistent with our previous results (33) and reports by other investigators (15), we found increased mRNA and protein expression for TRPC1 and TRPC6 in PASMCs exposed to hypoxia (Fig. 3) . Like SOCE, these increases were inhibited by treatment with sildenafil under hypoxic conditions. TRPC1 is primarily thought to function as SOCC subunits in pulmonary arterial smooth muscle (4, 8, 24) . For example, treatment with an antisense oligonucleotide targeted to TRPC1 reduced TRPC1 gene expression and SOCE in human PASMCs (29) , whereas overexpression of human TRPC1 in rat pulmonary arterial rings enhanced contractile responses to CPA, but not KCl (13) . Knockdown of TRPC1 with siRNA in rat PASMCs attenuated cation influx induced by thapsigargin (15) . Regarding TRPC6, although it is usually considered to form ROCC and thought to play an essential role in hypoxic pulmonary vasoconstriction (HPV), evidence in various cell types including PASMCs suggests that TRPC6 can also act as SOCC. For instance, upregulated TRPC6 was found to correlate with increased SOCE in proliferative PASMCs; inhibition of TRPC6 expression with antisense oligonucleotides or bosentan reduced the amplitude of SOCE induced by passive store depletion and attenuated mitogen-mediated PASMCs proliferation (13, 39, 40) . In human hepatoma cells, siRNA-mediated knockdown of TRPC6 decreased SOCE as well as the rate of cell proliferation (9) . Consistent with the results from the literature, we found that a profound knockdown of TRPC1 or TRPC6 in PASMCs led to significant reduction in the hypoxic increases of SOCE in association of decreased basal [Ca 2ϩ ] i ; however, neither of them alone was capable of diminishing these hypoxia-induced increases, indicating that both play a role in maintaining the increased level of basal [Ca 2ϩ ] i . If TRPC1 and TRPC6 were subunits of SOCC in PASMCs, the data shown in Figs. 1-2 suggest that the number of SOCC could be smaller in cells treated with sildenafil and lead to reduced SOCE and thus lower basal [Ca 2ϩ ] i during prolonged hypoxia exposure.
In the above ex vivo studies, a single dose of sildenafil of 300 nM was chosen because it attributes to ϳ90% of maximal inhibition on PDE activity in partially purified fractions from rat PASMCs according to a previous dose-response report (22) . Consistent with this inhibition on PDE activity by sildenafil, we found significant reduction of the hypoxic increases of basal [Ca 2ϩ ] i , which were associated with decreases in SOCE and TRPC1/TRPC6 expression in rat PASMCs.
Increased expression of TRPC caused by CH is associated with rise in [Ca 2ϩ ] i , which in turn may cause increased tone, proliferation, and migration of PASMCs (28) , thus contributing to the development of CHPH. Sildenafil has been shown to inhibit the development of CHPH in animal models (2, 10, 25, 38) . To confirm the therapeutic effect of sildenafil, we exposed rats to CH (10% O 2 for 21 days). Compared with the measurements in normoxic control animals, CH induced a rise in RVP and a significant increase of right ventricular hypertrophy. These increases were accompanied by increases of mRNA and protein expression of TRPC1 and TRPC6 in distal PA, consistent with our previous results (33) . Initiation of sildenafil (50 mg · kg Ϫ1 · day
Ϫ1
) at the same time of CH exposure significantly inhibited the increases of RVP and the progression of right ventricular hypertrophy. These inhibitory effects of sildenafil were associated with decreases in the mRNA and protein expression of TRPC1 and TRPC6 in distal PA. The dose of 50 mg · kg Ϫ1 · day Ϫ1 of sildenafil was selected from the effective range of 10 -75 mg · kg Ϫ1 · day Ϫ1 shown by others in attenuating rat CHPH (2, 10, 25) , and a previous safety study indicating "no-toxic-effect" dose level of sildenafil under 60 mg · kg Ϫ1 · day Ϫ1 in rats (1) . Indeed, we did not observe significant changes either in body weight or in the weights of major organs (liver and kidney) with sildenafil treatment under both normoxic and CH conditions, suggesting that the inhibitory effects of sildenafil on TRPC expression were unlikely due to toxicity. Interestingly, while treatment with sildenafil for 21 days decreased right ventricular hypertrophy in CH rats, it actually caused increases of mass ratio of RV/(LV ϩ S) and RV/body weight in normoxic rats. The mechanism accounting for this change is currently unknown.
In conclusion, we found that sildenafil inhibited CH-induced increases of basal [Ca 2ϩ ] i and SOCE in PASMCs. These functional effects of sildenafil were correlated with decreased expression of TRPC1 and TRPC6 transcripts and proteins. Moreover, sildenafil inhibited chronically hypoxic upregulation of TRPC1 and TRPC6 in distal pulmonary arterial smooth muscle from rats that developed CHPH. Our results from this study provide additional mechanistic information of sildenafil in regulating calcium signaling in PASMCs, and in treatment of CHPH, suggesting TRPC1 and TRPC6 as potential molecular targets in the clinical management of PH.
